GEN Biotechnology
sciencepublication
GEN Biotechnology: Exozymes for Biomanufacturing: Toward Clarity and Precision in the Cell-Free Space (cover story)April 17, 2025
Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler Korman
investorpress clippingsvideoscience
Bloomberg TV: Jane King interviews co-founder and VP of Research, Dr. Tyler KormanApril 15, 2025
BioClick - an enzyme engineering game-changer
press releaseinvestorscience
BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grantApril 10, 2025
World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial Officer
investorpress clippings
World Bio Market Insights: eXoZymes appoints Damien Perriman as Chief Commercial OfficerApril 3, 2025
Transcript: eXoZymes 4th quarter and full Year 2024 update from April 2, 2025
investor
Transcript: eXoZymes 4th quarter and full Year 2024 update from April 2, 2025April 3, 2025
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO
talentpress releaseinvestorvideo
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCOApril 2, 2025
eXoZymes Provides Fourth Quarter and Full Year 2024 Update
press releaseinvestor
eXoZymes Provides Fourth Quarter and Full Year 2024 UpdateApril 2, 2025
Chemical Engineering: Enzyme engineering breaks out of the cell
press clippingsscience
Chemical Engineering: Enzyme engineering breaks out of the cellApril 1, 2025
eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025
press releaseIPOinvestor
eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025March 26, 2025
Fox Business: Interview with Chief Market Strategist, Lou Basenese
investorpress clippingsvideo
Fox Business: Interview with Chief Market Strategist, Lou BaseneseMarch 17, 2025
Previous page
Page 6 of 11
Next page